OBIO

Orchestra BioMed Holdings, Inc.

Nasdaq · CIK 1814114

Last close5.95
Daily change-0.40 (-6.30%)
10 Years gain-47.81%
Dividends TTM0
Dividend yield0.00%

Fundamental Analysis

OBIO · STANDARD

SIC 3841 · Surgical & Medical Instruments & Apparatus · Fiscal year end 1231

Screener
Fundamental
42.6
Momentum
0.0
Acceleration
0.0
Confidence
63.0
Annual Revenue4
Quarterly Revenue14
Annual CFO5
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth17.3 / 25
Quality8.1 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5

Signals

Net debt reductionNet debt declined versus the comparison period.

Warnings

Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 2.1803 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 2390.867 percentage points.
Heavy share dilution · HIGHDiluted share count increased 66.8927%.

Key Metrics

Revenue Growth TTM-41.75%OK
Revenue CAGR 3Y111.62%OK
Gross Margin91.98%OK
Operating Margin-4,436.52%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y66.89%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2025 FY Dec 31, 2025$33.48M$33.29M-$51.81M-$48.96M-$49.45M99.43%-154.73%-147.7%n/a47.75M
2025 FY Dec 31, 2024$2.64M$2.43M-$64.30M-$50.56M-$50.85M92.27%-2,437.49%-1,927.48%n/a36.82M
2024 FY Dec 31, 2023$2.76M$2.57M-$51.51M-$46.13M-$46.21M93.26%-1,866.16%-1,674.09%n/a33.23M
2023 FY Dec 31, 2022$3.53M$3.32M-$32.66M-$29.29M-$29.88M94.03%-924.34%-845.74%n/a14.99M
2022 FY Dec 31, 2021n/an/a-$394,756.00-$272,362.00n/an/an/an/an/a20.45M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$1.90Msum latest 4 fiscal quarters RevenueOK0001104659-26-093357, 0001104659-25-109128
Revenue Growth TTM-41.75%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0001104659-26-093357, 0001104659-25-109128
Revenue CAGR 3Y111.62%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0001104659-26-026754
Revenue CAGR 5Yn/a(Revenue_current / Revenue_5Y_ago)^(1/5) - 1INSUFFICIENT_HISTORY0001104659-26-026754
Gross Profit CAGR 3Y115.6%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0001104659-26-026754
Operating Income Growthn/aOperatingIncome_current / OperatingIncome_prior_year - 1INSUFFICIENT_HISTORY0001104659-26-093357, 0001104659-25-109128
FCF Growthn/aFCF_current / FCF_prior_year - 1INSUFFICIENT_HISTORYderived
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin91.98%Gross Profit / RevenueOK0001104659-26-093357, 0001104659-25-109128
Operating Margin-4,436.52%Operating Income / RevenueOK0001104659-26-093357, 0001104659-25-109128
Net Debt / CFOn/aNet Debt / CFONOT_MEANINGFUL0001104659-26-093357
Current Ratio8.26xCurrent Assets / Current LiabilitiesOKderived
Revenue per Diluted Share$0.03Revenue / Diluted SharesOK0001104659-26-093357, 0001104659-25-109128
SBC / FCFn/aSBC / FCFNOT_MEANINGFULderived
Dividend Payout Ration/aCash dividends paid / Net incomeNOT_MEANINGFUL0001104659-26-026754